VOR vs IMCR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VOR Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vor Biopharma Inc. Common Stock (VOR) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while IMCR counters with relative strength in Valuation. Fundamentally, VOR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus IMCR at 23.8x Forward P/E and -2.2% operating margin (-1.4% YoY). In options structure, VOR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against IMCR sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VOR | IMCR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $1.6B | Larger Scale | IMCR |
| Trailing P/E Ratio Valuation | 0.1x | 23.8x | Lower Multiple | VOR |
| Forward P/E Ratio Valuation | N/M | 23.8x | Lower Multiple | IMCR |
| Revenue Growth (YoY) Growth | +0.0% | -1.4% | Higher Growth | VOR |
| Operating Margin (TTM) Profitability | 0.0% | -2.2% | Higher Margin | VOR |
| Net Profit Margin Profitability | 0.0% | -7.5% | Higher Margin | VOR |
| Return on Equity (ROE) Capital Efficiency | -125.4% | -7.9% | Higher ROE | IMCR |
| 52-Week Range Position Momentum | 65% ($6โ$26) | 12% ($28โ$41) | Stronger Trend | VOR |
| Beta / 30D Volatility Risk Regime | 1.91ฮฒ ยท 61% Vol | 0.63ฮฒ ยท 59% Vol | Lower Realized Risk | IMCR |
| Unified Institutional Score Composite Signal | 57.8 / 100 (HOLD) | 46.3 / 100 (HOLD) | Higher Composite | VOR |